Orkla adds UK sweet inclusions capacity with Phoenix Brands buy. The FY2025 revenue gap of 10 percent vs 1.5 percent for OFI explains the capital allocation. Q1 results Wednesday test margin trajectory.
Orkla has added another ingredient bolt-on ahead of its first-quarter earnings. The Norwegian group acquired Phoenix Brands, a UK-based B2B biscuits supplier, through its Orkla Food Ingredients (OFI) subsidiary Orchard Foods Valley (OV UK). Financial terms were not disclosed.
The acquisition tightens OFI’s grip on the sweet inclusions category, a manufacturing niche where Orkla’s ingredient arm competes for industrial bakery, dairy, bakery and confectionery customers. Sweet inclusions cover biscuit pieces, crunch elements and flavoured inserts – a specification-heavy segment with recurring revenue and higher switching costs than commodity biscuits.
“The company has built a focused and scalable platform with long standing customer relationships and a clear position within its niche,” OV UK CEO Coen Louwerse said in a statement.
Phoenix Brands, based in Wolverhampton in the West Midlands, produces digestives, bourbons and bourbons for bakery, dairy and confectionery customers. Andy Richards, the managing director, will remain with the business. Orkla’s pattern in earlier bolt-ons has been to retain the management team to preserve operational continuity.
Tor Osmundsen, CEO of OFI’s sweet ingredients unit, described the deal as “well aligned with our strategy of strengthening our ingredients portfolio through targeted investments in attractive categories with strong fundamentals.”
The sweet inclusions category carries higher margins than Orkla’s retail averages. Industrial customers sign long-term contracts based on technical capability and consistent quality. Switching costs are high. Once a supplier qualifies for a bakery or ice cream production line, replacement is expensive. That is the structural moat OFI is buying.
This is the second OFI acquisition in 2025. In February, Orkla bought Senna, an Austrian margarine and sauce and dressing producer from Vivatis Holding, a transaction that strengthened OFI’s footprint in central and south-eastern Europe. Phoenix Brands does the same for the UK market.
The two deals** show a deliberate pattern. OFI is absorbing bolt-ons that add technical manufacturing heft in specific ingredient categories – sauces in central Europe, sweet inclusions in the UK.
The M&A cadence fits the FY2025 revenue disclosure tells investors why OFI gets the capital allocation.
| Segment | FY2025 Revenue | Revenue (Nkr) | YoY Growth --- | --- | --- Orkla Food Ingredients (OFI) | 21.3bn | +10% Orkla Foods | 20.9bn | +1.5% Orkla Snacks | 10.5bn | +7.8%
The revenue gap between Orkla Foods (+1.5%) and OFI (+10%) is the strategic tailwind. Group-level revenue totalled Nkr71.05bn ($7.6bn) in 2025, up 3.5%%. Adjusted EBIT climbed 7.1% to Nkr7.65bn. Net profit doubled to Nkr12.06bn. OFI is the segment with the highest top-line momentum and the highest marginal return on invested capital. Management is funnelling acquisition budget there.
Orkla reports first-quarter results on Wednesday. The Phoenix Brands deal is too small – and the price undisclosed – to move the stock on its own. The Q1 print is the real catalyst.
Investors need two things from the release. First, confirmation that OFI can sustain double-digit organic growth without relying entirely on acquisitions. Second, evidence that integration costs from Senna and the new Phoenix Brands purchase are not compressing the unit’s operating margin.
The key line item is OFI’sweet inclusions margin. If OFI’s adjusted EBIT margin holds or expands, the roll-up thesis gains credibility. If it contracts, the market will discount the Phoenix Brands acquisition as expensive complexity.
Bottom line for traders: Wednesday’s Q1 results test whether OFI’s operational leverage offset the drag from the broader food business. OFI margin flat or up is bullish for the bolt-on strategy. OFI margin down postpones the story until Q2 or Q3.
Andy Richards staying with the business reduces execution risk, which Orkla has historically prioritised in its bolt-on playbook. The CEO of OV UK pointed to “long standing customer relationships and a clear position within its niche.” Those relationships are the asset Orkla is buying – not just the Wolverhampton production line.
For Orkla shareholders, the Phoenix Brands deal reinforces a capital allocation story that was already visible in the FY2025 numbers. Wednesday’s Q1 results will either confirm that OFI is compounding profitably or raise questions about how fast management can digest two deals in four months.
Prepared with AlphaScala research tooling and grounded in primary market data: live prices, fundamentals, SEC filings, hedge-fund holdings, and insider activity. Each story is checked against AlphaScala publishing rules before release. Educational coverage, not personalized advice.